Beta Bionics, Inc. — Director's Dealing 2025

Feb 4, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Beta Bionics, Inc. (BBNX)
CIK: 0001674632
Period of Report: 2025-01-31

Reporting Person: Saint Sean (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-01-31	Employee Stock Option (right to buy)	$7.51	A	749445	Acquired	2032-07-31	Common Stock (749445)	Direct
2025-01-31	Employee Stock Option (right to buy)	$7.51	A	83268	Acquired	2032-07-31	Common Stock (83268)	Direct
2025-01-31	Employee Stock Option (right to buy)	$5.10	A	494198	Acquired	2033-09-13	Common Stock (494198)	Direct
2025-01-31	Employee Stock Option (right to buy)	$5.10	A	54911	Acquired	2033-09-13	Common Stock (54911)	Direct
2025-01-31	Employee Stock Option (right to buy)	$17	A	467944	Acquired	2035-01-28	Common Stock (467944)	Direct

Footnotes

F1: One-fourth of the shares subject to this option shall vest one year after August 1, 2022, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof.

F2: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.

F3: The shares subject to this option shall vest in 12 equal monthly installments measured four years after August 1, 2022.

F4: One-fourth of the shares subject to this option shall vest one year after August 15, 2022, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof.

F5: The shares subject to this option shall vest in 12 equal monthly installments measured four years after August 15, 2022.

F6: Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts.